Skip to main contentAll experts

ProfessorChristopher Chiu

Professor of Infectious Diseases

Department of Infectious Disease - Faculty of Medicine

Orcid identifier0000-0003-0914-920X (opens in a new tab)⁠
  • Professor of Infectious Diseases
    Department of Infectious Disease - Faculty of Medicine
  • 020 8383 8231 (Work)
  • 8N.15, Commonwealth Building, Hammersmith Campus, United Kingdom

PROFESSIONAL ACTIVITIES

  • EXTERNAL COMMITTEE
    Evaluation, Analytics and Research Sub-group of the London Immunisation Board
    1 Mar 2019
  • GUEST LECTURE
    Imperial Network for Vaccine Research (INVaR): collaborative approaches to tackling global vaccine challenges
    13 Feb 2019
    London School of Hygiene and Tropical Medicine
  • GUEST LECTURE
    Accelerating vaccine development through innovation in experimental medicine
    1 Feb 2019
    Imperial Forum Workshop
  • GUEST LECTURE
    Human challenge with H3N2 influenza
    13 Nov 2018
    MRC HIC-Vac
  • GUEST LECTURE
    Protective immunity in human experimental influenza & RSV infection
    6 Nov 2018
    London Infections and Immunity Symposium
  • GUEST LECTURE
    Human influenza challenge studies: cellular immunity in the respiratory tract
    18 Sep 2018
    Public Health England
  • GUEST LECTURE
    The role of Controlled Human Infection Models in the licensure of vaccines
    26 Jun 2018
    World Health Organisation
  • GUEST LECTURE
    The challenges of respiratory viral infection
    15 Jun 2018
    University of Ghent
  • GUEST LECTURE
    The challenges of respiratory viral infection
    6 Jun 2018
    Cambridge University
  • GUEST LECTURE
    The challenge of RSV vaccination
    19 Apr 2018
    Imperial College London
  • GUEST LECTURE
    Protection and pathogenesis in experimental human infections with influenza and RSV
    21 Mar 2018
    Cardiff University
  • COLLABORATION
    Glaxo Smith Kline
    1 Feb 2018
    Edith Hessel - Respiratory viral infection of lower airways in COPD
  • AWARD
    Accelerating respiratory syncytial virus vaccine development in elderly adults through extension of the controlled human infection model: a pilot safety study
    1 Jan 2018
    GlaxoSmithKline
  • COLLABORATION
    Washington University, St Louis
    1 Dec 2017
    Ali Ellebedy - Influenza-specific B cells
  • GUEST LECTURE
    Dissecting immunity against RSV using human challenge trials
    20 Sep 2017
    IABS/WHO 2nd Human Challenge Trials Conference
  • GUEST LECTURE
    Pathogenesis & protective immunity in experimental human infection with influenza & RSV
    14 Sep 2017
    Institut Pasteur
  • GUEST LECTURE
    Influenza H1N1pdm infection of healthy volunteers
    1 Sep 2017
    European Scientific Working group on Influenza (ESWI)
  • COLLABORATION
    GlaxoSmithKline
    1 Aug 2017
    Jean-Francois Toussaint - RSV human challenge
  • EXTERNAL COMMITTEE
    British Infection Association Council
    1 Jun 2017
  • EXTERNAL COMMITTEE
    FIS 2018 Organising Committee
    1 Jun 2017
  • COLLABORATION
    Imperial College London
    1 Jun 2017
    James Harker - IL-27 in human RSV
  • GUEST LECTURE
    Human infection with influenza & RSV: insights from comparative study
    1 May 2017
    EU FP7 PREPARE Annual Meeting
  • EXTERNAL COMMITTEE
    Preparedness working group
    1 May 2017
  • AWARD
    Prometheus: Experimental human challenge with pandemic influenza A(H1N1)2009 to predict infectivity
    1 Apr 2017
    US Department of Defence DARPA
  • AWARD
    COPD-like airway inflammation during RSV infection of older volunteers INFLAMMAGE
    1 Mar 2017
    MRC